TY - JOUR
T1 - Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B (Frontiers in Immunology, (2018), 9, 10.3389/fimmu.2018.00848)
AU - Pouw, Richard B.
AU - Gómez Delgado, Irene
AU - López Lera, Alberto
AU - Rodríguez de Córdoba, Santiago
AU - Wouters, Diana
AU - Kuijpers, Taco W.
AU - Sánchez-Corral, Pilar
PY - 2020/1/24
Y1 - 2020/1/24
N2 - There is an error in the Acknowledgments statement. The correct name for the funder “Spanish Ministerio de Economía y Competitividad” is “Spanish Instituto de Salud Carlos III.” A correction has been made to the Acknowledgments section: “We appreciate the technical assistance of Lorena Risueño, César Vélez, and Álex Otero in the management of biological samples of patients and controls. We thank Rosario Madero (IdiPAZ Biostatistics) for statistical help, and Vega Mauleón and Hoi Tong (IdiPAZ UCICEC) for blood sampling of the healthy Spanish volunteers. This study was funded by the Spanish Instituto de Salud Carlos III and the European Program FEDER (grants PI12/00597 and PI16/00723 to PS-C, and grant SAF2015-66287-R to SR), and by the Complement II-CM network (B2017/BMD-3673). RP and TK received funding from the European Union’s seventh Framework program under ECGA no. 279185 (EUCLIDS; www.euclids-project.eu). AL is supported by the Spanish Center for Biomedical Network Research on Rare Diseases (CIBERER).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - There is an error in the Acknowledgments statement. The correct name for the funder “Spanish Ministerio de Economía y Competitividad” is “Spanish Instituto de Salud Carlos III.” A correction has been made to the Acknowledgments section: “We appreciate the technical assistance of Lorena Risueño, César Vélez, and Álex Otero in the management of biological samples of patients and controls. We thank Rosario Madero (IdiPAZ Biostatistics) for statistical help, and Vega Mauleón and Hoi Tong (IdiPAZ UCICEC) for blood sampling of the healthy Spanish volunteers. This study was funded by the Spanish Instituto de Salud Carlos III and the European Program FEDER (grants PI12/00597 and PI16/00723 to PS-C, and grant SAF2015-66287-R to SR), and by the Complement II-CM network (B2017/BMD-3673). RP and TK received funding from the European Union’s seventh Framework program under ECGA no. 279185 (EUCLIDS; www.euclids-project.eu). AL is supported by the Spanish Center for Biomedical Network Research on Rare Diseases (CIBERER).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
KW - CFHR3 gene
KW - atypical hemolytic-uremic syndrome
KW - complement
KW - factor H
KW - factor H-related protein 3
UR - http://www.scopus.com/inward/record.url?scp=85079106923&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fimmu.2019.03073
DO - https://doi.org/10.3389/fimmu.2019.03073
M3 - Erratum/Corrigendum
C2 - 32038624
SN - 1664-3224
VL - 10
JO - Frontiers in immunology
JF - Frontiers in immunology
M1 - 3073
ER -